Literature DB >> 9989948

Latency of varicella zoster virus; a persistently perplexing state.

P R Kinchington1.   

Abstract

Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles. These distinct diseases are separated by a lengthy period of latency, often lasting decades, in which the virus resides within the ganglia of the host. VZV latency and reactivation from it have, for the most part, been extraordinarily difficult to examine. This is due to the lack of a good animal model for the VZV latent state, the inability to experimentally reactivate VZV under any circumstances and the caveats and problems encountered in examining human ganglionic tissue. However, insights into features of the molecular events of VZV latency have been gleaned from its pathogenesis and from recent advances in molecular probing of human and animal ganglia. Evidence suggests that the latent VZV genome may express transcripts unlike those of closely related herpesviruses, and some evidence suggests an unusual site for the establishment of VZV latency. In this review, the current evidence for events occurring during the VZV latent state will be discussed, from a view of its pathogenesis as well as its molecular biology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989948     DOI: 10.2741/kinchington

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.

Authors:  F S Hasnie; J Breuer; S Parker; V Wallace; J Blackbeard; I Lever; P R Kinchington; A H Dickenson; T Pheby; A S C Rice
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

2.  Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.

Authors:  Mireille T M Vossen; Mi-Ran Gent; Karla M C Peters; Pauline M E Wertheim-van Dillen; Koert M Dolman; Alex van Breda; René A W van Lier; Taco W Kuijpers
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

4.  Productive varicella-zoster virus infection of cultured intact human ganglia.

Authors:  Kavitha Gowrishankar; Barry Slobedman; Anthony L Cunningham; Monica Miranda-Saksena; Ross A Boadle; Allison Abendroth
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 5.  Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy.

Authors:  Barry T Rouse; D Scott Schmid
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

6.  Varicella-zoster virus infection of human neural cells in vivo.

Authors:  Armin Baiker; Klaus Fabel; Antonio Cozzio; Leigh Zerboni; Konstanze Fabel; Marvin Sommer; Nobuko Uchida; Dongping He; Irving Weissman; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

7.  ORF9p phosphorylation by ORF47p is crucial for the formation and egress of varicella-zoster virus viral particles.

Authors:  Laura Riva; Marc Thiry; Sebastien Bontems; Aline Joris; Jacques Piette; Marielle Lebrun; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

8.  The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3.

Authors:  Patricia Vandevenne; Marielle Lebrun; Nadia El Mjiyad; Isabelle Ote; Emmanuel Di Valentin; Yvette Habraken; Estelle Dortu; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

9.  CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.

Authors:  Kristen Haberthur; Flora Engelmann; Byng Park; Alex Barron; Alfred Legasse; Jesse Dewane; Miranda Fischer; Amelia Kerns; Monica Brown; Ilhem Messaoudi
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

10.  Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection.

Authors:  Thomas J Goodwin; Maureen McCarthy; Nikolaus Osterrieder; Randall J Cohrs; Benedikt B Kaufer
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.